Synopsis of Social media discussions
The discussions overwhelmingly support the study's positive outcomes, with phrases like 'practice-changing trial' and references to improved cardiovascular outcomes, indicating strong agreement and perceived high impact. The tone is professional and technical, with many examples citing specific trial names like FIDELIO, FIGARO, and detailed statistics, which demonstrate a high level of interest and engagement in advancing treatment strategies.
Agreement
Strong agreementMost discussions express strong support and highlight the positive results of the finerenone trials, emphasizing its effectiveness and potential as a practice-changing treatment.
Interest
High level of interestThe posts show high academic and professional interest, referencing detailed trial outcomes, primary endpoints, and clinical implications.
Engagement
Moderate level of engagementWhile many posts delve into clinical details and implications, some are reposts or summaries, indicating moderate engagement with some variation in depth.
Impact
High level of impactThe overall tone reflects the belief that these findings significantly influence current treatment approaches for CKD and T2D, suggesting a high impact in nephrology and cardiology fields.
Social Mentions
YouTube
4 Videos
Bluesky
1 Posts
8 Posts
304 Posts
Blogs
6 Articles
News
62 Articles
Metrics
Video Views
617
Total Likes
380
Extended Reach
1,273,346
Social Features
385
Timeline: Posts about article
Top Social Media Posts
Diego Segura-Rodríguez
view full post
Nephrology Journal Club
Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC
https://t.co/xQq6AKyHGA https://t.co/qVaEOBvWGp
view full post
Edgar V. Lerma
FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline
FIDELIO-DKD https://t.co/T6Tq2388a1
FIGARO-DKD https://t.co/r1V46C0aSU
FIDELITY https://t.co/PgJJR8kI8B
#VisualAbstract by @whatsthegfr
#ISNWCN
view full post
José R. Juanatey
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejorar el pronóstico de diabéticos con enfermedad renal crónica! @secardiologia #ESCcongress https://t.co/mJK0PygMiF
view full post
Dr Amar Puttanna
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @drpatrickholmes @drkevinfernando @kamleshkhunti @cardiomet_CE @GoggleDocs @brendonneuen @VladoPerkovic @SABOURETCardio @hvanspall @ErinMichos @docwas
view full post
Posts referencing the article
Impact of Dapagliflozin on Kidney Health in IgA Nephropathy
In this academic review, Professor Matthias Girndt presents key studies from 2021, focusing on significant findings from the DAPA-CKD trial. The trial demonstrated that dapagliflozin effectively reduces kidney complications and improves kidney health in patients with IgA nephropathy.
December 23, 2021
582 views
Optimizing Catheter Ablation Strategies for Persistent Atrial Fibrillation
Catheter ablation for persistent atrial fibrillation is less effective than for paroxysmal types. A study of 589 patients shows that pulmonary vein isolation alone results in better outcomes and shorter procedures compared to additional substrate modifications, with similar complication rates.
March 27, 2024
17 views
Analyzing Cardiovascular and Kidney Disease Management Strategies
This week, John Mandrola MD examines statin intolerance and the impact of new medications like finerenone on chronic kidney disease in type 2 diabetes. He discusses the effectiveness of finerenone in reducing kidney-related complications and its additional cardiovascular benefits.
March 27, 2024
14 views
Finerenone's Impact on Cardiovascular and Kidney Outcomes in Diabetes
This study examines finerenone, a mineralocorticoid receptor blocker, and its effects on cardiovascular and kidney outcomes in patients with type 2 diabetes and chronic kidney disease, showing significant reductions in major cardiovascular events.
August 11, 2025
5 views
-
RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postAugust 26, 2025
178
-
Mohamed E. Elrggal
@M_Elraggal (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postAugust 26, 2025
178
-
Ahmed Serageldeen
@ahmed_shaban_s (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postAugust 26, 2025
178
-
Roberto Gutiérrez
@DrRobertoGuti (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 9, 2025
178
-
NephroLOGY BOX. GUO's
@ulusalokyay (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 9, 2025
178
-
diacavan
@diacavan (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Karo Vivanco✌
@Karovivanco29 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Magaly Abarca Pineda
@Magalyabarca (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Vademon24292
@CarlosA09557330 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Erik on the Run
@Erik_RB16b (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Franklin Loachamin
@FranLoachamin (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Nep
@HadiMD_ (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
Milagros Flores
@dra_miliflores (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 8, 2025
178
-
nyiminhan
@nyiminhan (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 7, 2025
178
-
د علي السهو FRCPC, FASN, FISN
@alialsahow (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 7, 2025
178
-
Manuel Gaxiola
@cardiogax (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 6, 2025
178
-
Mohammad Aleidi
@aleidimed (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 6, 2025
178
-
marc0
@markosycc (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 6, 2025
178
-
Edson Makambwa
@EdsonMakambwa (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postJune 6, 2025
178
-
KittyKat555
@KatieSh74387435 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 29, 2025
178
-
TISOYMD
@TisoyMDSays (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 23, 2025
178
-
Johanna Calib Macataman
@itsjohannacm (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 21, 2025
178
-
Nefrología UMAE 71
@NefroUmae71 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 17, 2025
178
-
Sayed S. Rahman
@SayedSRahman1 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 16, 2025
178
-
Sophia Crawford
@Crawford2Sophia (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 10, 2025
11
-
Nikhil Bassi, MD
@NikhilBassiMD (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 9, 2025
11
-
Jez Chua
@jezchuamd (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 6, 2025
178
-
Pedro Betancourt
@Pedrob251 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 5, 2025
178
-
Clinical cardiology
@Mahmoud33986639 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 4, 2025
178
-
Dr. Ambily K
@drambilyk (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 3, 2025
178
-
Irving Trejo Curiel
@irvtc (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 3, 2025
178
-
Koushik Chakma
@Koushikchak2013 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 3, 2025
178
-
Bhavya dasara
@bhavya_dasara (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
MariGeli
@yo32185 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
MariGeli
@GeliYo32185 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
José Luiz
@nefrotweets (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
Nefrología HRLALM
@NefroHRLALM (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
Ale Padron
@nefroalejapatch (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
EmmaHuang
@EmmaHuang81 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 2, 2025
178
-
Dr.Trauma_Do
@Dr_Trauma_do (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Alina Martin
@alinamartin811 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Natsir Ramadhan
@natsiradhan (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Ibn Aris
@ibenzimidazole (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Nefrologo Roman Hernandez Rios
@NefroRomanHdez (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Alexandro Franco Estrada
@AlexEstradaF (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Dr. No
@DRCRITICALCARE3 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Goaty 2 am
@OGoaty5 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Sara Almutar
@s_almutar (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Dr. Carlos Orellana
@orellanamd (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
diacavan
@diacavan (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
さく
@za_yi (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
Ppp
@Pingg_niP (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Laura Pérez
@tatana2007 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Laura Pérez
@tatana2007 (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
Carmela Ramos
@carmelanefro (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Oscar
@OscarAlfredoLu4 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Miguel Turégano
@tureyedro (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
M. Azman Pasha
@PandAzman (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Juan Santiago
@JohnLMJ (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Sam
@spanday31 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
diacavan
@diacavan (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Julio César
@DrJulioMatuteM (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Marcello Di Zenzo
@ZenzoMarcello (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Aarthi Muthukumaran
@aarthi_dr (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Luis Ribeiro
@ribeiro_queiros (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Vincci Monique Salud, M.D.
@moniquecularMD (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Takuya Kishi @ねこ好き循環器内科医
@tkishi_cardiol (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
M Azfar Qureshi
@MAQ_Renal (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
R A Popalzai
@Radion_Popalzai (Twitter)RT @drbennisahmed: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD wi…
view full postMarch 1, 2025
11
-
Ahmed Bennis MD
@drbennisahmed (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes In type 2 diabetes and stage 2 to 4 CKD with elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, finerenone therapy improved cardiovascular outcomes https://t.co/qOGe2abT4i https://t.co/jczBKaaqSO
view full postMarch 1, 2025
19
11
-
Estefanía Argüello
@tefitasaloata (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Namesh kamat
@namesh217 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
MedEd Global Solutions
@global_meded (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Victor Hernández
@VicHdez27 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Mike Tenckhoff
@miguel_mgtz7 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Manika Adari
@ManikaAdari (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
GHAZALI, M.D
@MGhazali225 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Emmanuel Bailon
@2807Mababa (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Caps, MD
@Caaaapslock_ (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Diana Zambri
@dianitazambri (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Abc
@abraham_0699 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postMarch 1, 2025
178
-
Mayra Avilés
@marsdance21 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
S.Runprapan
@wwanderlusterr (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Cristhian Muñoz
@CristhianMuM (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Armando Morales S.
@amsnefrologo (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Cardiogrumpy
@Khabelo (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Spandana Ravada Vora
@spandanaravada (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Dr Theepa N.M.R
@TNesam (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Joyce Bwombengi
@kemuntoMD (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
そらまめ医
@YiSoramame (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
refntokyo
@tokyo_Oli_drift (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Brian Ricardo Garibay Vega
@BrianGaribayV (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Pawan Rao MD, FASN
@nephronus (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Prawesh Adhikari
@PraweshAdhikar1 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
CLEO
@CleoKrg (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Alsun Cabarles
@HarriZoon (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
EOLO MORANDI JR.
@eolojr (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
rubensg.
@un_rubens (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Aurora Beatriz Tutiven Ubilla
@AuroraTutiven (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Nader
@Nader62321135 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Nefrología CMN SXXI
@NefroCMNSXXI (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Ken Lim, MD PhD
@TheLimLab (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Elías
@ElasV05 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Umut Kocabaş
@UmutKocabasMD (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Muthu Vaduganathan
@mvaduganathan (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Dr NAGA SHASHIKANTH P
@NagaShashikanth (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Almansour
@malmansour81 (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Clemente Porras
@Memeporras (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Lamri Aldjia
@AldjiaLamri (Twitter)RT @edgarvlermamd: Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
178
-
Edgar V. Lerma
@edgarvlermamd.bsky.social (Bluesky)Finerenone trials #PSHPLAS
view full postFebruary 28, 2025
11
5
-
Misato Chimura
@chim97834 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
Laura Pérez
@tatana2007 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
Juan Pablo Flores
@JuanPablo_Fs (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
Muthu Vaduganathan
@mvaduganathan (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
Juan Carlos Obaya
@jcobaya69 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
Doc Dorin
@doriny27 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 11, 2024
15
-
H. A. A.
@tondercath (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Dr. Carlos Orellana
@orellanamd (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Ana Oliva
@AnaOliva31 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Leo Vin
@nefro40 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Carmela Ramos
@Carmen98607067 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Sarah Melville
@sarahkmels (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 10, 2024
15
-
Cristina Popa
@NephroSeeker (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 9, 2024
15
-
Elba Medina
@elbaonelida (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 9, 2024
15
-
د.خديجة خويلد
@PNdfwf0e0TPPBY6 (Twitter)RT @NephJC: Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patient…
view full postOctober 9, 2024
15
-
Nephrology Journal Club
@NephJC (Twitter)Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC https://t.co/xQq6AKyHGA https://t.co/qVaEOBvWGp
view full postOctober 9, 2024
51
15
-
Swapnil Hiremath @hswapnil.medsky.social
@hswapnil (Twitter)RT @NephJC: After FIDELIO, Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone fo…
view full postOctober 8, 2024
2
-
Nephrology Journal Club
@NephJC (Twitter)After FIDELIO, Finerenone was flexing its muscles in the cardiology world with evidence from FIGARO. Anyone using finerenone for their patients with HF, DM, and CKD? #NephJC https://t.co/xQq6AKy9R2
view full postOctober 8, 2024
14
2
-
Joyce Bwombengi
@kemuntoMD (Twitter)RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:
view full postJune 10, 2024
3
-
Jose De La Flor
@josedelaflor4 (Twitter)RT @NephJC: Evidence on efficacy
view full postMay 23, 2024
1
-
Nephrology Journal Club
@NephJC (Twitter)Evidence on efficacy
view full postMay 22, 2024
5
1
-
Nephrology Journal Club
@NephJC (Twitter)Evidence on efficacy
view full postMay 21, 2024
4
-
cardio-met
@cardiomet_CE (Twitter)32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs
view full postJune 7, 2023
-
Juan Carlos Obaya
@jcobaya69 (Twitter)RT @cardiomet_CE: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…
view full postJune 6, 2023
2
-
Juan Carlos Obaya
@jcobaya69 (Twitter)RT @cardiomet_CE: 15) #FIGARODKD was also a practice changing trial:
view full postJune 6, 2023
2
-
Ahmed Mohsen
@drahmedmohsen85 (Twitter)RT @cardiomet_CE: 15) #FIGARODKD was also a practice changing trial:
view full postJune 6, 2023
2
-
Ahmed Mohsen
@drahmedmohsen85 (Twitter)RT @cardiomet_CE: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…
view full postJune 6, 2023
2
-
Ahmed Mohsen
@drahmedmohsen85 (Twitter)RT @cardiomet_CE: 11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney…
view full postJune 6, 2023
1
-
cardio-met
@cardiomet_CE (Twitter)15) #FIGARODKD was also a practice changing trial:
view full postJune 6, 2023
2
2
-
cardio-met
@cardiomet_CE (Twitter)12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained ↓ #eGFR > 40% or kidney death) ▶️ ↓ ~14% in composite CV outcome This is a practice changing RCT : in pts with #T2D & #CKD with ↑ #UACR finerenone, ↓ heart & kidney risk
view full postJune 6, 2023
3
2
-
cardio-met
@cardiomet_CE (Twitter)11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney complications despite maximal ACEi/ARB, with no compelling indications for steroidal #MRA (e.g., #CHF)
view full postJune 6, 2023
4
1
-
Ahmed Mohsen
@drahmedmohsen85 (Twitter)RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:
view full postMay 31, 2023
3
-
JorgeEdoChava75
@QicenoJorge (Twitter)RT @cardiomet_CE: 35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:
view full postMay 31, 2023
3
-
cardio-met
@cardiomet_CE (Twitter)35) In the #SGLT2i and #MRAtrials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:
view full postMay 31, 2023
4
3
-
@CKD_ce
@ckd_ce (Twitter)32) #FIDELIODKD & #FIGARODKD included subgroup analyses in younger v older individuals, hidden in supplements or follow up pubs
view full postMay 25, 2023
1
-
DidemTurgut
@didemturgut_ (Twitter)RT @ckd_ce: 15) #FIGARODKD was also a practice changing trial:
view full postMay 24, 2023
1
-
DidemTurgut
@didemturgut_ (Twitter)RT @ckd_ce: 12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained drop in #eGFR > 40% or kidney death) ▶️ ↓ ~14% in…
view full postMay 24, 2023
1
-
DidemTurgut
@didemturgut_ (Twitter)RT @ckd_ce: 11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney compli…
view full postMay 24, 2023
1
-
@CKD_ce
@ckd_ce (Twitter)15) #FIGARODKD was also a practice changing trial:
view full postMay 24, 2023
2
1
-
@CKD_ce
@ckd_ce (Twitter)12) #FIDELIODKD in a nutshell: ▶️ ↓ ~20% in kidney outcomes (#ESKD, sustained drop in #eGFR > 40% or kidney death) ▶️ ↓ ~14% in composite CV outcome This is a practice changing RCT: in pts w/#T2D & #CKD w/ ↑ #UACR finerenone, ↓ heart & kidney risk
view full postMay 24, 2023
2
1
-
@CKD_ce
@ckd_ce (Twitter)11) #FIGARODKD & #FIDELIODKD studied #finerenone in pts with #T2D & #CKD at ↑risk (↑#UACR) for #cardiovascular & #kidney complications despite maximal ACEi/ARB, with no compelling indications for steroidal #MRA(e.g., #CHF)
view full postMay 24, 2023
2
1
-
Viet Le DMSc PA-C FACC FAHA HF-Cert
@VietHeartPA (Twitter)@brianrosePAS We will miss you! Will be tonight my friend. Important to educate on nsMRA benefits to reduce CKD progression and reduce ASCVD events (driven by HF hosp and… cv death!). https://t.co/bAsbsQs6rw #AAPA23 @APAC_Cardiology https://t.co/y00qzR0oZ3
view full postMay 21, 2023
-
@CKD_ce
@ckd_ce (Twitter)35) In the #SGLT2i and #MRA trials, pts w/ #T2D who received active treatment had ⬇️ in #UACR:
view full postMay 18, 2023
1
-
Héctor Rodrigo Rodríguez
@HRodrigoRV (Twitter)FIGARO Trial 13% menos eventos de cardiovasculares: 29% menos hospitalizaciones por ICC
view full postApril 16, 2023
-
Daniel Schwartz, MD
@drdschwartzmd (Twitter)Finerenone was studied in FIDELIO and FIGARO & enrolled when SGLT2i were not yet standard care https://t.co/VA1VwHO0AO https://t.co/WsR99nPP06
view full postNovember 29, 2022
2
-
Edgar V. Lerma
@edgarvlermamd (Twitter)@drrayms @gbakris It is hypothesized that finerenone might potentially help mediate an effect on pneumonia & #COVID19: improvements in pulmonary inflammation & fibrosis, upregulation of expression of ACE2, amelioration of R heart pressure & pulm. congestion #Nephpearls
view full postOctober 26, 2022
-
The Rounds Table
@roundstable (Twitter)Pitt et al examined whether finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist, would improve cardiovascular outcomes in patients with kidney disease and type 2 diabetes. Read more here https://t.co/AyjDfwmeFK
view full postSeptember 7, 2022
1
-
Naheed
@nsali2 (Twitter)@EzequielZaidel @thaiscoutinhoCV Yes it is. Finerenone, a selective nonsteroidal mineralocorticoid receptor antagonist sounds better. https://t.co/QdfWC2BRR8
view full postJuly 1, 2022
-
ぽん@
@pharma_pon (Twitter)腎臓病および2型糖尿病におけるフィネレノンによる心血管イベント Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/5kLrNxMfEK
view full postJune 17, 2022
1
-
Erik Abel
@erik_e_abel (Twitter)Think I missed these at the end 2021, all the more reason that early disease detection is key, particularly with interventions like SGLT2i in DM2 or these in DM2 with cardiorenal disease with Finerenone FIGARO: https://t.co/9bcMbi43EK FIDELIO: https://t.co/MdAX55SnSZ.
view full postMay 4, 2022
-
さくなお＠腎×小児薬剤師
@sakunao_study (Twitter)新しいMR治療薬「フィネレノン」という薬が2型糖尿病を合併するCKDの心血管イベント発現や腎臓病進展を抑制する働きがあるとは！ Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/aw1bhBUHEC
view full postMarch 28, 2022
-
Manu Morales Sánchez
@Manugrillo2 (Twitter)RT @FGarridoB: Según el FIGARO-DKD, Finerenona no solo retrasa la progresión de la enfermedad renal, sino que también previene los eventos…
view full postMarch 23, 2022
4
-
د. سلطان خالد
@sul111ksa (Twitter)@SultanS_Alotaib @B_ALDAAJANI Two RCTs: FIDELIO-DKD and FIGARO-DKD trails الاولى شاركها اخوي سلطان والثانية https://t.co/x45QdGC1VE
view full postMarch 15, 2022
2
-
The Cardiometabolic Forum
@theCMforum (Twitter)Pitt et al. suggests desirable effects on cardiorenal outcomes in patients with stage 3 or 4 CKD, T2D and severely elevated albuminuria. View our summary slides on the publication here: https://t.co/5yopwRbubx
view full postMarch 6, 2022
-
The Cardiometabolic Forum
@theCMforum (Twitter)A double-blind, placebo-controlled, event-driven Phase 3 trial by Pitt et al. randomised 7,437 patients to RAS blockade plus either finerenone or placebo, to investigate cardiorenal outcomes. View our summary slides now: https://t.co/5yopwRbubx
view full postMarch 5, 2022
-
Letaief
@hmidato (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 28, 2022
18
-
Dr Bishal Agarwalla
@bishalagarwalla (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
Ana Maria Matias
@AMCMA6 (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
Santiago Moreno T.
@santy431 (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
Princesarann
@Princesarann1 (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
Basu Gopal
@BasuNephro (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
DidemTurgut
@didemturgut_ (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 27, 2022
18
-
Benito Valdepenas
@Benitocept (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Gustavo Guevara Nolivos.
@gpguevara_nefro (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
ISN Education
@ISNeducation (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
4
-
Dr Theepa N.M.R
@TNesam (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Paul mobey
@mpobey (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
4
-
Jen Li
@DrJenLi_Renal (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Jen Li
@JLi_Renal (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
World Congress of Nephrology
@ISNWCN (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
4
-
ReVolBER
@RevolberMex (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Anace Pastor ✨️ Renalis
@anace710 (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Anace Pastor ✨️ Renalis
@anace710 (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
4
-
Hermann Hernández MD.
@HERMANNHV (Twitter)RT @edgarvlermamd: FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co…
view full postFebruary 26, 2022
18
-
Edgar V. Lerma
@edgarvlermamd (Twitter)FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co/T6Tq2388a1 FIGARO-DKD https://t.co/r1V46C0aSU FIDELITY https://t.co/PgJJR8kI8B #VisualAbstract by @whatsthegfr #ISNWCN
view full postFebruary 26, 2022
32
18
-
Edgar V. Lerma
@edgarvlermamd (Twitter)FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline FIDELIO-DKD https://t.co/T6Tq2388a1 FIGARO-DKD https://t.co/r1V46C0aSU FIDELITY https://t.co/PgJJR8kI8B #VisualAbstract by @whatsthegfr #ISNWCN
view full postFebruary 26, 2022
8
4
-
DiabetoPitie
@DiabetoPitie (Twitter)2/3 https://t.co/wHDIWH42ub
view full postFebruary 22, 2022
1
-
Hugo Diniz, MD
@HDiniz_ (Twitter)RT @SPNefro: Publication alert!
view full postFebruary 16, 2022
1
-
Sociedade Portuguesa de Nefrologia
@SPNefro (Twitter)Publication alert!
view full postFebruary 16, 2022
3
1
-
Eduardo Hernández
@EduardoHn46 (Twitter)#FIGARO-DKD *7352 pacientes con ERC 2-4 con alb/Cr urinaria 30-300 o ERC 1-2 con alb/Cr urinaria 300-5000 + DT2 *Muerte CV o IAM en 458 (12,4%) con #Finerenona vs 519 (14,2%) con placebo (HR 0,87; P=0,03) *Hospitalización por falla cardiaca (HR 0,71) DOI: 10.1056/NEJMoa2110956 https://t.co/MvOAIRxTu8
view full postFebruary 3, 2022
-
cardio-met
@cardiomet_CE (Twitter)RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…
view full postJanuary 20, 2022
3
-
AcademicCME
@academiccme (Twitter)RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…
view full postJanuary 20, 2022
3
-
soda_troubles,https://med-mastodon.com/@haysam
@set_fortess (Twitter)RT @ckd_ce: 22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://…
view full postJanuary 20, 2022
3
-
@CKD_ce
@ckd_ce (Twitter)22) FIGARO-DKD explored impact of finerenone in pts with #T2D & a wider range of #CKD. Unlike FIDELIO-DKD, FIGARO-DKD (https://t.co/kSVp01OkN1) had a primary CV endpoint & a secondary renal endpoint but less advanced CKD. Nearly half had #microalbuminuria; mean eGFR was 68ml/min
view full postJanuary 20, 2022
5
3
-
Gunnar Henrik Heine
@gunnar_heine (Twitter)@dgfn_ev https://t.co/AOldrTpX0D
view full postDecember 28, 2021
-
Taiga
@tigktym (Twitter)RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN
view full postDecember 23, 2021
3
-
ときヲ
@toki_wo_koe (Twitter)RT @uni_pharmacist: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uXvvsGAEn2
view full postDecember 22, 2021
1
-
unimusashi（N. Ashikawa）
@uni_pharmacist (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uXvvsGAEn2
view full postDecember 22, 2021
3
1
-
macky
@mackyTigers (Twitter)国産MRBエサキセレノンは一体何やってんだ。のんびりしてるとあっちゅう間に追い抜かれるぞ Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ajVyuMnrtv
view full postDecember 22, 2021
-
Drぷー
@Dr_ppooohh (Twitter)RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN
view full postDecember 22, 2021
3
-
Hiroyuki Sato 佐藤宏行
@foreverhero0819 (Twitter)RT @CircSM: DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN
view full postDecember 22, 2021
3
-
ShingoMatsumoto
@CardioSM (Twitter)DM合併CKDへのfinerenone、有意にイベント抑制 MRAてほんとすごいですね そしてPitt先生の一貫性もすごい #NEJM https://t.co/G6l6ohBkwN
view full postDecember 22, 2021
17
3
-
Billy Osler III
@SmrtMedNews (Twitter)@NEJM 1/79 treated patients, (only 15% on GDMT, only 70% on statin) may delay a CHF hospitalization, without MI/CVA/GFR/ESRD benefit, is this really "clinically relevant? " @NephJC @ASNKidney #chf #hf #medtwitter #MedEd #NephJC #NephTwitter #nephrology https://t.co/rVyZYQNQH2
view full postDecember 22, 2021
-
Jesus Casado
@JesusCasado20 (Twitter)RT @IcyfaSemi: Finerenona en DM con FG entre 25-90 ml/min y albuminuria : ⬇️el MACE ampliado con
view full postDecember 18, 2021
12
-
Giuseppe Biondi-Zoccai
@gbiondizoccai (Twitter)RT @cpgale3: In this RCT of 7437 participants with type 2 #diabetes & stage 2 to 4 #CKD with moderately elevated albuminuria or stage 1 or…
view full postDecember 17, 2021
1
-
Prof Chris P Gale
@cpgale3 (Twitter)In this RCT of 7437 participants with type 2 #diabetes & stage 2 to 4 #CKD with moderately elevated albuminuria or stage 1 or 2 CKD with severely elevated albuminuria, #finerenone therapy improved #cardiovascular outcomes as compared with placebo. https://t.co/eYFzEvTxGt
view full postDecember 17, 2021
4
1
-
Lorenzo Bertomeu
@LorenzoBertome1 (Twitter)RT @ValleAlfonso:
view full postDecember 15, 2021
12
-
VICTOR SANNA
@VICTORSANNA (Twitter)RT @ASPNeph: Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 #Diabetes. #CKD @NEJM https://t.co/UlIlN5d3YD
view full postDecember 14, 2021
1
-
American Society of Pediatric Nephrology
@ASPNeph (Twitter)Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 #Diabetes. #CKD @NEJM https://t.co/UlIlN5d3YD
view full postDecember 14, 2021
2
1
-
Jose Carlos Arevalo
@joscarlor2 (Twitter)RT @ManoloBeltranR: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ucqr5dGdGe
view full postDecember 12, 2021
1
-
Manuel Beltrán
@ManoloBeltranR (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ucqr5dGdGe
view full postDecember 12, 2021
4
1
-
Luis Caminal
@caminalm (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/uWKpSlkOQT
view full postDecember 12, 2021
-
Fernando Civeira
@FernandoCiveir1 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/690tXvFuYR
view full postDecember 9, 2021
1
-
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/iNv5i5OFLT
view full postDecember 8, 2021
1
-
Repositorio ABACUS
@AbacusUE (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/B5lgwBeL3H
view full postNovember 27, 2021
-
青島周一
@syuichiao89 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/xTiyuIXJdn
view full postOctober 4, 2021
1
-
CardiologyTalk
@CardiologyTalk (Twitter)Podcast- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes, Bertram Pitt, M.D. - @UMich @UMichCardiology #CardiovascularEvents #Cardiology #research Link to Audio- https://t.co/4y52ccfC8i https://t.co/E0YTGDbVJK
view full postSeptember 23, 2021
-
CardiologyTalk
@CardiologyTalk (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes, Bertram Pitt, M.D. - @UMich @UMichCardiology #CardiovascularEvents #Cardiology #Research https://t.co/33hprMHWhd https://t.co/FXTKxN3Q3g
view full postSeptember 23, 2021
-
Beatriz Fernandez Fernandez
@beaff26 (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postSeptember 11, 2021
9
-
Aaron Liew MB BCh, MPH, PhD
@AARONLYL (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/QFIVlghXav
view full postSeptember 7, 2021
2
-
Mohamed Hamedh MSc, MD
@mohamedhamedh2 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/KR4dNyaClx
view full postSeptember 7, 2021
1
-
Cardio Renal Metabolic Connections
@cardio_renal (Twitter)RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb
view full postAugust 31, 2021
3
-
Cat Shah
@NPlubdub (Twitter)RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb
view full postAugust 31, 2021
3
-
Rodolfo J. Galindo MD
@RodolfoJGalindo (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…
view full postAugust 29, 2021
5
-
Javier Escalada #Yoelijoendocrino
@fjavesc (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…
view full postAugust 29, 2021
5
-
Ingrid Billaut
@IBillaut (Twitter)RT @SeguraCardio:
view full postAugust 29, 2021
19
-
Linda
@wordfinga (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 29, 2021
9
-
Manu Morales Sánchez
@Manugrillo2 (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 29, 2021
16
-
Eduard Centeno
@segol60 (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 29, 2021
11
-
IGOARANBA
@IGOARANBAR (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 29, 2021
9
-
Pablo Perez Martinez
@PabloPerezMar16 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/d3U30LuSHa
view full postAugust 29, 2021
2
-
fausto heredia z.
@drfherediaz (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 29, 2021
16
-
Giuseppe Maltese
@docmaltese (Twitter)RT @SurendranAarthi: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ZbcbIs9jI2. CVO impro…
view full postAugust 29, 2021
1
-
Paula Madalina Lupu
@PaulaMadalinaL1 (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 29, 2021
9
-
Linda
@wordfinga (Twitter)RT @mzkhalil: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. | NEJM #ESCCongress https://t.co/HgOH6veEnT
view full postAugust 29, 2021
1
-
Felice Gragnano
@FeliceGragnano (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 29, 2021
16
-
Héctor Meckler
@mecklerh (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 29, 2021
11
-
Edgard Manrique Alva
@Manriqardio (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Ivan Mendoza
@mencardio (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Carlos Maiorana
@MaioranaCarlos (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
todayheadline
@TodayHeadline42 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes – https://t.co/ZYBwqO9hdm https://t.co/HQcNn9KlUd
view full postAugust 28, 2021
-
Linda Lopez-George, Ed.D.
@LindaLopezGeo1 (Twitter)RT @SBansalNeph: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb
view full postAugust 28, 2021
3
-
Oscar Andres
@OscarAndresMD (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…
view full postAugust 28, 2021
5
-
Euro Journal - English News
@eurojournalENG (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/LoHW2aQdsh
view full postAugust 28, 2021
-
the paper link
@the_paper_link (Twitter)Trend new: Pitt B, ..., Figaro-dkd Investigators (N Engl J Med) __Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes__ https://t.co/MGSVd5IQyR
view full postAugust 28, 2021
-
Professor M Z Khalil
@mzkhalil (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. | NEJM #ESCCongress https://t.co/HgOH6veEnT
view full postAugust 28, 2021
1
1
-
名前
@akkiii0830 (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/PRoQjOxyeQ
view full postAugust 28, 2021
-
Aarthi Surendran
@SurendranAarthi (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/ZbcbIs9jI2. CVO improves with finerenone in patients with CKD 2-4. Bear in mind hyperkalaemia. @DrMohamedBakhit @docmaltese @drdanidixon @drpatrickholmes @drkevinfernando
view full postAugust 28, 2021
6
1
-
Shweta Bansal
@SBansalNeph (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/fdfOYPjoVb
view full postAugust 28, 2021
5
3
-
José Luis Añorga Ocmin, MD
@Joseluis_MD29 (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Dr. Jose Gabian Fortes
@gabianfortes (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Dr Jean Pierre Laroche #vacciné 6.0
@Echoraljpangio (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/mA51ksVAOy https://t.co/NC92ojTScC
view full postAugust 28, 2021
-
Dr. Shashank Joshi
@AskDrShashank (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
CNCFCardio
@CNCFCardio (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Peter Rossing
@P_Rossing (Twitter)RT @FrederikPersson: Remember to measure UACR in #T2D and start best treatment. Now from @P_Rossing from @Stenodiabetes and global investi…
view full postAugust 28, 2021
1
-
Angela Romero Zarante, MD
@ANGELARZ28 (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Angela Romero Zarante, MD
@ANGELARZ28 (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
juan lopez
@jd1lopez (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Diego Bellido
@DiegoBellido2 (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
Julio
@yulnunezvill (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Dr.Rajiv Sankaranarayanan
@DrRajivsankar (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Flora López Simarro
@flopezsim (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
Rosa Fernandez
@MAROSFO (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Oscar Moreno #
@moreno_perez_o (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
Ekaterini Lambrinou
@EkateriniL (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Vicente Arrarte
@varrarte (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…
view full postAugust 28, 2021
5
-
Vicente Arrarte
@varrarte (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Dani Salas
@pollitodeanaga (Twitter)RT @JoseJuanatey: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejo…
view full postAugust 28, 2021
11
-
Dani Salas
@pollitodeanaga (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Fco Carramiñana Barrera
@fcbzafra (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
GT Diabetes Semergen
@SemergenGTDM (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
redGDPS Diabetes
@redGDPS (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
José R. Juanatey
@JoseJuanatey (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM crece el Arsenal terapéutico para mejorar el pronóstico de diabéticos con enfermedad renal crónica! @secardiologia #ESCcongress https://t.co/mJK0PygMiF
view full postAugust 28, 2021
21
11
-
Manu Morales Sánchez
@Manugrillo2 (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Javier Torres
@JTLLERGO (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Anja
@piepsi_228 (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
fausto heredia z.
@drfherediaz (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patient…
view full postAugust 28, 2021
5
-
Laura Alvarez
@pipertaza (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
champ_wayne
@champ_wayne (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
C. Delgado ☯️
@cris_pitita (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/KmUXG7R3kK
view full postAugust 28, 2021
-
Ryan Chizner, DO, MPH, RPVI, FACC
@ChiznerRyan (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Khalill Peeroo
@Khalill_ (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Guillaume Bonnet
@guilbon (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Jose Luis Górriz
@jlgorriz (Twitter)RT @CristobMorales: https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SED…
view full postAugust 28, 2021
9
-
Adrián RH
@_telurio (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Maja Cikes
@MajaCikes (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Manu Morales Sánchez
@Manugrillo2 (Twitter)Cardiovascular Events with #Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/dFRCqtt7I4
view full postAugust 28, 2021
-
Cristobal Morales
@CristobMorales (Twitter)https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @sociedadSEEN @SEDiabetes @SENefrologia @secardiologia @redGDPS @SEMERGENap @ValleAlfonso @fjavesc @jlgorriz @almucastro01 @DrTinahones @DiegoBellido2 @moreno_perez_o https://t.co/H5ETEhI6dT
view full postAugust 28, 2021
18
9
-
CardioEd Bot
@CardioBot (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
Charles Pollack MD
@md_pollack (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Kevin Fernando
@drkevinfernando (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
cardio-met
@cardiomet_CE (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Cristobal Morales
@CristobMorales (Twitter)https://t.co/OMHZm2Q4SU Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes @NEJM Among patients with t2DM and stage 2 to 4 CKD with moderately albuminuria or stage 1 or 2 CKD with severely albuminuria, finerenone therapy improved cardiovascular outcomes
view full postAugust 28, 2021
10
5
-
Kenar Jhaveri
@kdjhaveri (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | @NEJM https://t.co/LJRotsuX7d
view full postAugust 28, 2021
11
-
Dimitris Papamargaritis
@ri_tis (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Dr. Michael Alexander
@MichaelAlexandp (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes | NEJM https://t.co/IXnTNOZ1Fj
view full postAugust 28, 2021
-
Harriette Van Spall, MD MPH
@hvanspall (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Dr Umesh Prabhu
@DrUmeshPrabhu (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Dr. Martha Gulati ♥️
@DrMarthaGulati (Twitter)RT @SeguraCardio:
view full postAugust 28, 2021
19
-
GoggleDocs
@GoggleDocs (Twitter)RT @AmarPut: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @d…
view full postAugust 28, 2021
9
-
Alessia Gimelli
@alessia_gimelli (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
Diego Segura-Rodríguez
@SeguraCardio (Twitter)August 28, 2021
63
19
-
Dr Amar Puttanna
@AmarPut (Twitter)Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes https://t.co/qIj6cpt27y @escardio #ESCCongress @drpatrickholmes @drkevinfernando @kamleshkhunti @cardiomet_CE @GoggleDocs @brendonneuen @VladoPerkovic @SABOURETCardio @hvanspall @ErinMichos @docwas
view full postAugust 28, 2021
20
9
-
Muneeb Jan
@manutd91 (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
-
European Society of Cardiology
@escardio (Twitter)RT @Drroxmehran: #FIGARO-DKD at #ESCCongress In CKD pts w/ mod/sev albuminuria, controlled SBP & HbA1c & on optimal RAS blockade, finerenon…
view full postAugust 28, 2021
16
Abstract Synopsis
- The study investigated the effects of finerenone, a medication that blocks mineralocorticoid receptors, on cardiovascular and kidney outcomes in patients with type 2 diabetes and different stages of chronic kidney disease (CKD).
- Patients were randomly given either finerenone or a placebo, and the main focus was on preventing serious cardiovascular events such as heart attacks, strokes, or heart failure hospitalizations, with secondary outcomes including kidney failure and significant decline in kidney function.
- Results showed that finerenone significantly reduced the risk of major cardiovascular events compared to placebo, mainly by lowering hospitalizations related to heart failure, suggesting it may be beneficial for a broader range of CKD patients with type 2 diabetes.
Marco Anaya_NefroX
@Nefrotweet (Twitter)